Gores Holdings III, Inc. (PAE), which recently held their shareholder vote to complete their combination with PAE on Friday, February 7th, announced this morning that they have now closed their acquisition.
PAE, which is a Platinum Equity portfolio company, was founded in 1955 and is a leading provider of mission-critical services to the U.S. government, armed forces and international customers including the U.S. Department of State, Army, Navy, Air Force, NASA and others. Headquartered in Falls Church, Virginia, PAE operates in approximately 60 countries across all seven continents.
At Friday’s vote, the transaction was approved by shareholders and while we don’t have an exact vote count yet, Gores III released that 0.0005% of shareholders redeemed, which is roughly 200 shares. This is another great result in a string of great results from SPAC combinations. Today’s announcement from Gores III, also follows the success of Platinum Equity’s other portfolio company, Vertiv, which recently combined with GS Acquisition Holdings (now VRT), which is currently trading at ~$13.06. Platinum Equity is having a very good week.
Gores Holdings III has been renamed PAE Incorporated and its common stock and warrants will trade on the Nasdaq under the symbols “PAE” and “PAEWW”, respectively.
ADVISORS
- Deutsche Bank Securities Inc. and Evercore acted as lead financial advisors to Gores Holdings III.
- Deutsche Bank Securities Inc. also acted as lead capital markets advisor
- Evercore, BofA Securities and Morgan Stanley & Co, LLC also acted as capital markets advisors
- Moelis & Company LLC acted as financial advisor.
- Weil, Gotshal & Manges LLP acted as legal advisor to Gores Holdings III.
- Latham & Watkins LLP acted as legal advisor to Platinum Equity and PAE.
Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. Latest SPAC News: NYSE president says IPO proceeds fall more than 90% while Nasdaq president remains hopeful for 2023, and Giuliani brothers sell pharma stocks as they invest in biotech SPACs NYSE president says IPO proceeds fall...
InterPrivate II Acquisition Corp. (NYSE:IPVA) disclosed this morning that it has restructured its bonus share agreement in connection to its proposed merger with carsharing marketplace Getaround. The parties previously agreed to reserve and set aside the bonus shares, consisting of 9,333,333 shares, to be allocated to the non-redeeming public stockholders, the designees of EarlyBirdCapital and the...
Iris Acquisition Corp. (NASDAQ:IRAA) has entered into a definitive agreement to combine with biotech firm Liminatus at an enterprise value of $334 million. La Palma, California-based Liminatus is a clinical-stage drug developer working on a range of cancer treatments utilizing both preventative vaccines and CAR-T therapies. The combined company is expected to trade on the...
Lakeshore Acquisition Corp. I (NASDAQ:LAAA) announced this morning that it has entered into a non-redemption agreement and amended its purchaser support agreement with initial shareholders in connection to its proposed merger with medical device company ProSomnus. The SPAC entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the purchaser. These investors...
The companies and sponsors of six SPAC deals are set to see their lock-ups expire before the end of the year. This is a relatively small monthly total as the wave of deals from 2020 and 2021 are still hitting this milestone. The list nonetheless includes some major names starting with Forafric (NASDAQ:AFRI), which is...